WuXi AppTec
2025.06.16
07:24
The Hang Seng AH Premium Index hit a five-year low, and some companies experienced a "H-share premium" phenomenon
Since the beginning of this year, the Hong Kong stock index has risen strongly as a whole, outperforming major global stock indices during the same period, and the Hang Seng AH Premium Index has continued to fall. On June 12, the index hit an intraday low of 126.91 points, a new low since June 2020. As of the close of June 13, the Hang Seng AH Premium Index was at 128.05 points. The index has fallen by more than 10% overall this year. The premium of A shares relative to H shares has always been a common phenomenon. Currently, 42 companies still have an AH premium rate of more than 100%. At the same time, the number of companies with A shares at a discount to H shares has gradually increased. The H-share prices of CATL, WuXi AppTec, and China Merchants Bank are all higher than A shares. Many industry insiders believe that the AH spread is expected to continue to narrow in the short term, and the current changes may herald the beginning of a new round of long-term trends.
2025.06.12
13:20
Hong Kong-listed biopharmaceutical stocks strengthened again in the afternoon, with Rongchang Biopharma (09995.HK) rising more than 20%, Zai Lab (09688.HK) rising more than 10%, Junshi Biosciences (01877.HK) and BeiGene (06160.HK) rising more than 7%, Kelun Biotech (06990.HK) rising more than 6.5%, and WuXi AppTec (02359.HK) rising more than 5%.
09:55
Hong Kong-listed biopharmaceutical stocks rose in early trading, with Zai Lab (09688.HK) up more than 8.5%, Kelun Biotech (06990.HK) up nearly 6%, BeiGene (06160.HK) up more than 4%, Rongchang Biopharmaceuticals (09995.HK), WuXi Biologics (02269.HK), InnoCare Pharma (09969.HK), and WuXi AppTec (02359.HK) all up more than 3%.
2025.06.03
17:02
WuXi AppTec: Repurchased 6.6828 million shares with a total capital of RMB 400 million
WuXi AppTec announced that the company held a board meeting on April 8, 2025 to review and approve the share repurchase plan, planning to use 1 billion yuan of funds to repurchase shares through centralized bidding to maintain the company's value and shareholders' interests. As of May 31, 2025, the company has repurchased a total of 6.6828 million shares, accounting for 0.2314% of the company's total share capital, with a repurchase price range of 52.52 yuan/share to 64.71 yuan/share, and a total of 400 million yuan in funds (excluding transaction fees). The company will continue to implement repurchases based on market conditions and disclose relevant progress in a timely manner.
2025.05.29
13:50
A-share CRO concept stocks strengthened in the afternoon, Zhaoyan Pharmaceutical hit the daily limit, Ruizhi Pharmaceutical and Lianhua Technology had previously closed the board, MediSci rose more than 10%, and Kaile Pharmaceutical, Corning Life Sciences, Northrop Grumman, and WuXi AppTec followed suit.
13:41
CRO concept rebounded and Zhaoyan New Drug hit the daily limit
CRO concept rebounded, Zhaoyan Pharmaceutical hit the daily limit, MediSci rose more than 10%, and Kaile Pharmaceutical, Corning Life Sciences, Northrop Grumman, and WuXi AppTec followed suit.
2025.05.27
09:56
Hong Kong-listed pharmaceutical stocks rose, with Agilent Technologies rising more than 7%.
Hong Kong-listed pharmaceutical stocks rose, with CStone Pharmaceuticals rising more than 7%, followed by Corning Life Sciences, WuXi Biologics, WuXi AppTec, and Zhaoyan Pharmaceutical.
09:42
The Hong Kong stock market's biopharmaceutical sector strengthened, with Zai Lab (09688.HK) rising nearly 3%, WuXi Biologics (02269.HK) rising nearly 2%, and WuXi AppTec (02359.HK), Rongchang Biopharma (09995.HK) and others following suit.
2025.05.22
09:37
The Hong Kong stock market's biopharmaceutical sector fell back and weakened, with Tiger Pharmaceuticals (03347.HK) falling nearly 3%, Rongchang Biopharma (09995.HK) falling more than 2%, BeiGene (06160.HK), WuXi AppTec (02359.HK) and others following suit.
2025.05.21
09:59
Hong Kong-listed pharmaceutical stocks rose, with Agilent Technologies up nearly 9%
Hong Kong-listed pharmaceutical stocks rose, with CStone Pharmaceuticals rising nearly 9%, followed by Kangfang Biopharma, 3SBio, WuXi Biologics, CSPC Pharmaceutical Group, and WuXi AppTec.
2025.05.14
17:05
WuXi AppTec: 2024 equity distribution cash dividend per share of 1.33 yuan
WuXi AppTec announced that the company's 2024 and 2025 A-share equity distribution plan for special dividends to shareholders has been approved by the shareholders' meeting. The cash dividend per A-share is 1.33 yuan (tax included), of which the 2024 equity distribution is 0.98169 yuan (tax included) per A-share, and the 2025 special dividend equity distribution is 0.35 yuan (tax included) per A-share. The equity registration date is May 20, 2025, and the ex-rights (dividend) date and cash dividend payment date are May 21, 2025. The company's total A-share capital is 2.501 billion shares. After deducting 2.8559 million A-shares in the repurchase special securities account, the total number of A-shares actually participating in the distribution is 2.498 billion shares.
2025.05.02
13:23
The Hang Seng Biotech Index continued to expand its gains in the afternoon, with WuXi AppTec (02359.HK) rising nearly 8% and WuXi Biologics (02269.HK) rising more than 6%.
2025.04.30
09:21
Hong Kong stocks opened, the Hang Seng Index opened up 0.14%, the Tech Index opened up 0.21%. WuXi AppTec (02359.HK) rose more than 3%, and China Merchants Bank (03968.HK) fell more than 1% after the results.
2025.04.29
10:17
WuXi AppTec rose more than 5%, and the Biopharmaceutical ETF (159839) held 12.31% of the stock
WuXi AppTec's share price increase expanded to 5.08%. The Biopharmaceutical ETF (159839) holds 12.31% of the stock. The current increase is 0.94%, with a turnover of 6.449 million yuan and an increase of 273 million shares in the past month.
10:14
Hong Kong stocks rose, with the Hang Seng Index up more than 1%
Hong Kong stocks rose, with the Hang Seng Index up more than 1% and the Hang Seng Technology Index up nearly 2%. Innovative drugs and retail stocks led the gains. Leapmotor and WuXi AppTec rose more than 7%.
Load More
Email Subscription
Newsletters and emails are now available! Delivered on time, every weekday, to keep you up to date with North American business news.
Weekly Highlights
Air India flight returns after takeoff due to technical issues

2025-06-16

Southbound funds made a large net purchase of 5.743 billion yuan today. In terms of Hong Kong Stock Connect (Shanghai), China Construction Bank and Meituan-W received net purchases of HK$1.108 billion and HK$493 million respectively; Xiaomi Group-W ranked first in net sales, with an amount of HK$1.489 billion; in terms of Hong Kong Stock Connect (Shenzhen), Meituan-W and Kangfang Biopharma received net purchases of HK$622 million and HK$206 million respectively; Xiaomi Group-W ranked first in net sales, with an amount of HK$391 million.

2025-06-16

Arm (ARM.O): We are better than Nvidia on a wider range of platforms.

2025-06-12

Lei Jun: Xiaomi Yu7 will be released at the end of June

2025-06-16

Putin: Russia will create unmanned system forces as a separate branch of the military

2025-06-13

ASIA TECH WIRE

Grasp technology trends

Download